Bid Analysis Spreadsheet 3/09

University of Alabama at Birmingham 2/28

RFP 2.0 Viral Material Donation

Canji, Inc. 2/28

RFP 3.0 Donation of Supplies or Other Services

EM Processing 2/28
ATCC 2/28
EM Processing 2/28
Osmonics, Inc 2/28
Osmonics Distribution Agreement 2/28
Life Technologies Division of Invitrogen Corporation

RFP 4.0 Viral Bank Production and Testing Donation

Canji, Inc. 2/28

RFP 5.0 Purified Formulated Bulk Virus Reference Material Product and Release Testing Documentation

Introgen Therapeutics, Inc. 2/28

RFP 6.0 Vialing and Freezing Donation 2/28

Introgen Therapeutics, Inc. 2/28

RFP 7.0 Donation of Repository Services

ATCC 2/28

RFP 8.0 Participation in Assignment of Particle Concentration

Berlex BioSciences 7/02
Berlex BioSciences, SOP Pico Green 7/30  
Berlex BioSciences, SOP RP HPLC 7/30  
Transgene, SOP HPLC 7/02
Transgene 7/02
Transgene, Capabilities 7/02
Biotechnology Research Institute, OD 7/30
Biotechnology Research Institute, HPLC 7/30
Biotechnology Research Institute, SOP HPLC 7/30
Biotechnology Research Institute, Capabilities 7/30
Canji 7/30
Cell Genesys 7/30
Cell Genesys, Capabilities TaqMan 7/30
Cell Genesys, SOP TaqMan 7/30
Cell Genesys, Capabilities OD 7/30
Cobra Therapeutics 7/30
Covance 7/30
Genetic Therapy 7/30
Onyx 7/30
Onyx, SOP OD 7/30
Onyx, Capabilities 7/30
Qbiogene 7/30
Univ. Alabama Birmingham 7/30

RFP 9.0 Participation in Assignment of Infectious Titer

AppTec, ViroMed 7/30
ATCC 7/30
Berlex BioSciences 7/30  
Berlex BioSciences 8/31, SOP Endpoint Dilution
Canji 7/30
Cell Genesys 7/30
Cell Genesys, Capabilities 7/30
Cell Genesys, Capabilities FACS 7/30 
Cell Genesys, SOP FACS 7/30 
Biotechnology Research Institute, 7/30
Biotechnology Research Institute, SOP SDS PAGE 7/30
Biotechnology Research Institute, SOP Western Blot 7/30
Cobra Therapeutics 7/30
Covance 7/30
Genetic Therapy 7/30
Qbiogene 7/30
Q-One 7/30
Q-One, Capabilities 7/30
Transgene 7/30
Univ. Alabama Birmingham 7/30
Univ. of Texas 7/30

RFP 10.0 Participation in Characterization of Reference Material

Althea Technologies 7/30
Biotechnology Research Institute, 7/30
Canji 7/31
Canji, SOP EM 7/30
Transgene 7/30
Univ. of Texas 7/30
Univ. of Texas, SOP 7/30

RFP 11.0 Participation in Short-term and Field Stability Studies

Genetic Therapy 7/30
Transgene 7/30
Univ. Alabama Birmingham
Univ. of Texas 7/30

RFP 12.0 Participation in Long-term Stability Studies

Canji 7/30
Transgene 7/30
Univ. Alabama Birmingham 7/30

RFP 13.0 Donation of Supplies for Characterization Phase

Invitrogen 7/30
Pall 7/30

CAPABILITIES

CHARACTERIZATION   

CofA

CofA-1-UAB-3-20-MCB

CofA-1-UAB-3-20-Trypsin, FBS

CofA-4-Canji 2/28

 

SOP

Test Methods-Introgen 2/28